Organisation paid for research Program year 2024 Source: CMS Open Payments

Allcutis Research, Inc

Neither a doctor nor a teaching hospital

Research payments

$236,223

15 payments

Through program year 2024, Allcutis Research, Inc is reported as receiving $236,223 in research payments, across 15 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$60,756	5
2023	Research	$162,594	8
2022	Research	$12,873	2

Breakdown

Who paid Research payments · program years 2022–2024

Ucb SA $236,223 15 payments

Studies the money was for Research payments · program years 2022–2024

A Phase 3, open-label, parallel group, multicenter, extension study evaluating the long-term treatment of bimekizumab in study participants with moderate to severe hidradenitis suppurativa $177,307 8 payments
A Multicenter, Open-Label Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis $35,839 4 payments
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa $12,427 1 payment
A Multicenter, Open-Label, Randomized Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis $8,500 1 payment
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa $2,150 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.